These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21756851)

  • 1. Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease.
    Yu C; Xu C; Xu L; Yu J; Miao M; Li Y
    J Hepatol; 2012 Jan; 56(1):241-7. PubMed ID: 21756851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum proteomics for biomarker discovery in nonalcoholic fatty liver disease.
    Yilmaz Y
    Clin Chim Acta; 2012 Aug; 413(15-16):1190-3. PubMed ID: 22546610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Ulukaya E; Yilmaz Y; Moshkovskii S; Karpova M; Pyatnitskiy M; Atug O; Dolar E
    Scand J Gastroenterol; 2009; 44(12):1471-6. PubMed ID: 19883279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease.
    Franzini M; Fornaciari I; Fierabracci V; Elawadi HA; Bolognesi V; Maltinti S; Ricchiuti A; De Bortoli N; Marchi S; Pompella A; Passino C; Emdin M; Paolicchi A
    Liver Int; 2012 Apr; 32(4):629-34. PubMed ID: 22098947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
    Kaneda H; Hashimoto E; Yatsuji S; Tokushige K; Shiratori K
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics analysis of human nonalcoholic fatty liver.
    Rodriguez-Suarez E; Mato JM; Elortza F
    Methods Mol Biol; 2012; 909():241-58. PubMed ID: 22903720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
    Abid A; Taha O; Nseir W; Farah R; Grosovski M; Assy N
    J Hepatol; 2009 Nov; 51(5):918-24. PubMed ID: 19765850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
    Miele L; Forgione A; La Torre G; Vero V; Cefalo C; Racco S; Vellone VG; Vecchio FM; Gasbarrini G; Rapaccini GL; Neuman MG; Grieco A
    Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).
    Madan K; Bhardwaj P; Thareja S; Gupta SD; Saraya A
    J Clin Gastroenterol; 2006; 40(10):930-5. PubMed ID: 17063114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study.
    Xu C; Yu C; Ma H; Xu L; Miao M; Li Y
    Am J Gastroenterol; 2013 Aug; 108(8):1299-304. PubMed ID: 23567356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease.
    Senates E; Yilmaz Y; Colak Y; Ozturk O; Altunoz ME; Kurt R; Ozkara S; Aksaray S; Tuncer I; Ovunc AO
    Metab Syndr Relat Disord; 2011 Aug; 9(4):287-90. PubMed ID: 21417913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome.
    Yilmaz Y; Senates E; Ayyildiz T; Colak Y; Tuncer I; Ovunc AO; Dolar E; Kalayci C
    Eur J Clin Invest; 2012 Apr; 42(4):411-8. PubMed ID: 21913918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.
    Church TS; Kuk JL; Ross R; Priest EL; Biltoft E; Blair SN
    Gastroenterology; 2006 Jun; 130(7):2023-30. PubMed ID: 16762625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study.
    Li Y; Xu C; Yu C; Xu L; Miao M
    J Hepatol; 2009 May; 50(5):1029-34. PubMed ID: 19299029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China.
    Li H; Dong K; Fang Q; Hou X; Zhou M; Bao Y; Xiang K; Xu A; Jia W
    J Hepatol; 2013 Mar; 58(3):557-63. PubMed ID: 23142063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective cohort study of the predictive value of hemoglobin levels for non-alcoholic fatty liver disease].
    Cai W; Zhang B; Miao L; Wang T; Zou Y; Li Y; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):200-4. PubMed ID: 24824122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.